Clinical Study for the Evaluation of Safety & Tolerability of PRO-172

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05073744` - Nalbuphine Versus Morphine for Perioperative Tumor Ablation	Phase 4
Completed	`NCT03969641` - Safety of RIV4 Versus IIV4 in Pregnant Women	Phase 4
Completed	`NCT05592951` - Safety and Tolerability of a Novel Amino-acid Based Hydration Drink in Healthy Volunteers	N/A
Completed	`NCT01636024` - To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of Inhaled AZD7594	Phase 1
Completed	`NCT01415102` - A First In Human Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Single Inhaled Doses Of PF-05212372.	Phase 1
Completed	`NCT01243502` - A Study to Assess the Pharmacokinetics, Safety and Tolerability of CT327 in Healthy Male Volunteers	Phase 1
Completed	`NCT06072170` - Single Ascending Doses of Kratom in Healthy Nondependent Adults With Opioid Experience	Phase 1
Completed	`NCT05076253` - Efficacy of Ivermectin in COVID-19	Phase 1/Phase 2
Recruiting	`NCT06060379` - Giochiamo 626 - Gaming for Health and Safety in Workplaces	N/A
Recruiting	`NCT05298800` - Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23	Phase 4
Completed	`NCT05188638` - Safety of Ascending Single and Multiple Doses of Nebulised SoftOx Inhalation Solution in Healthy Subjects	Phase 1
Completed	`NCT05145621` - Oral Bio-equivalence Study	Phase 1
Recruiting	`NCT05580159` - New Generation mRNA Booster Vaccine Against Emerging VOCs	Phase 3
Not yet recruiting	`NCT04596956` - Safety and Efficacy of Sodium Bicarbonate Ringer Injection	Phase 4
Completed	`NCT03033329` - Single Dose Escalation and Multiple Dose Escalation Trial of an Intravenous Formulation of MRX-4	Phase 1
Terminated	`NCT01929811` - NeoMET Study in Neoadjuvant Treatment of Breast Cancer	Phase 2
Completed	`NCT01193335` - Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants.	Phase 4
Completed	`NCT03300466` - A Study to Evaluate the Performance and Safety of GP0045 for Correction of Moderate to Severe Nasolabial Folds	N/A
Active, not recruiting	`NCT05686161` - mRNA Booster Vaccine(SW-BIC-213) Compared With Pfizer andSinopharm Against Emerging VOCs	Phase 3
Recruiting	`NCT06046053` - MATRIX-002: Trial to Assess Acceptability and Safety of Two Placebo Vaginal Films	Early Phase 1

NCT number	NCT04693429
Study type	Interventional
Source	Laboratorios Sophia S.A de C.V.
Contact
Status	Completed
Phase	Phase 1
Start date	September 24, 2020
Completion date	December 8, 2020

Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+ — PRO-172

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms